<DOC>
	<DOCNO>NCT00950690</DOCNO>
	<brief_summary>Efficacy data collect analyzed . This study ass safety tolerability Xalatan .</brief_summary>
	<brief_title>Efficacy Tolerability Xalatan Patients</brief_title>
	<detailed_description>- Efficacy data collect analyzed - Safety tolerability Xalatan assess NA</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Patient ocular hypertension least 22mg Hg Patient must 18 year old None list protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>observational safety study</keyword>
</DOC>